News | September 02, 2023
Jupiter Life Line Hospitals’ IPO to open on Sept. 6
Sets price band at ?695 to ?735 per Equity Share
Sets price band at ?695 to ?735 per Equity Share
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The programme was conducted as a part of MPMCx, an exclusive management programme for MBBS doctors by IIM-Ahmedabad in collaboration with DailyRounds
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Subscribe To Our Newsletter & Stay Updated
